Market Value1,181,041,000
Total Holdings58
File Date2021-08-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
KNTE / Kinnate Biopharma Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
DSGN / Design Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
PRDS / Pardes Biosciences Inc
BMEA / Biomea Fusion, Inc.
GRPH / Graphite Bio, Inc.
PRLD / Prelude Therapeutics Incorporated
TALS / Talaris Therapeutics Inc
IPSC / Century Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
GHRS / GH Research PLC
RAPT / RAPT Therapeutics, Inc. Call
DAWN / Day One Biopharmaceuticals, Inc.
VERV / Verve Therapeutics, Inc.
HARP / Harpoon Therapeutics, Inc.
LABP / Landos Biopharma, Inc.
NKTX / Nkarta, Inc.
ATHA / Athira Pharma, Inc.
PMVP / PMV Pharmaceuticals, Inc.
KRTX / Karuna Therapeutics, Inc.
TPTX / Turning Point Therapeutics Inc
HSAQ / Health Sciences Acquisitions Corp 2
CGEM / Cullinan Therapeutics, Inc.
RPTX / Repare Therapeutics Inc.
ALGS / Aligos Therapeutics, Inc.
IKNA / Ikena Oncology, Inc.
ELDN / Eledon Pharmaceuticals, Inc.
RACB / Research Alliance Corp II - Class A
FMTX / Forma Therapeutics Holdings Inc
CCCC / C4 Therapeutics, Inc.
ALXO / ALX Oncology Holdings Inc.
CYTK / Cytokinetics, Incorporated
PASG / Passage Bio, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
IOVA / Iovance Biotherapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
ISEE / IVERIC bio Inc
TIL / Instil Bio, Inc.
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
RAPT / RAPT Therapeutics, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
ARYD / ARYA Sciences Acquisition Corp IV
RAIN / Rain Enhancement Technologies Holdco, Inc.
KZR / Kezar Life Sciences, Inc.
HLXA / Helix Acquisition Corp - Class A
TNGX / Tango Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
ANNX / Annexon, Inc.
ATXS / Astria Therapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
DYNE / Dyntek Inc
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
COGT / Cogent Biosciences, Inc.